Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Oculistica AB
AB
Active
Org 5591858088
Karl X Gustavs Gata 46, 254 39
Helsingborg
General medical practice activities
· NACE 8621
Est. 2018
1 employees
Watchlist
Share
Sweden
/
Companies
/
General medical practice activities
/
Oculistica AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
1M
2022
1M
2023
1M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
1M
2022
1M
2023
0M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
329
306
924
1 394
1 367
Staff expenses
—
—
—
—
−735
EBITDA
276
221
551
581
443
Depreciation & amort.
−0
−0
−0
−0
—
EBIT
276
221
551
581
443
Net financials
—
—
—
9
15
Profit before tax
276
222
551
591
458
Tax
−59
−46
−114
−122
−95
Net profit
217
176
437
469
363
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
458
457
917
1 250
1 309
Equity
303
298
549
737
896
Long-term debt
0
0
0
0
—
Short-term debt
155
158
368
512
412
Total debt
155
158
368
512
412
Financial ratios
5-year trend
EBITDA margin
32.4%
This company
15.8%
Market median
+105% vs market
2020
2024
Equity ratio
68.5%
This company
38.2%
Market median
+79% vs market
2020
2024
Return on equity
40.5%
This company
18.4%
Market median
+120% vs market
2020
2024
Net profit margin
26.6%
This company
8.1%
Market median
+228% vs market
2020
2024
Asset turnover
1.04×
This company
1.12×
Market median
+7% vs market
2020
2024
Debt / equity
0.46×
This company
0.62×
Market median
+26% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Oculistica AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network